Centre for Vision Research, Department of Ophthalmology, and The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, Australia.
Centre for Vision Research, Department of Ophthalmology, and The Westmead Millennium Institute for Medical Research, The University of Sydney, Sydney, Australia.
Ophthalmology. 2015 Dec;122(12):2482-9. doi: 10.1016/j.ophtha.2015.08.002. Epub 2015 Sep 14.
To assess the 15-year incidence and progression of age-related macular degeneration (AMD) in an older Australian population.
Population-based cohort study.
Blue Mountains Eye Study (BMES) participants (n = 3654) aged 49+ years were examined during 1992-1994. Of these, 2334 (75.8% of survivors) were reexamined after 5 years (1997-1999), 1952 (76.7% of survivors) after 10 years (2002-2004), and 1149 (56.1% of survivors) after 15 years (2007-2010).
Color retinal photographs were taken, and comprehensive questionnaires were administered at each visit and DNA was genotyped. Retinal photographic grading was performed by the same graders following the Wisconsin AMD grading protocol. Side-by-side comparisons were used to confirm newly developed AMD lesions. Incidence was estimated using Kaplan-Meier estimates. Associations of AMD incidence with age, sex, smoking status, presence of the complement factor H (CFH)-rs1061170 and age-related maculopathy susceptibility 2 (ARMS2)-rs10490924 polymorphisms, and fish consumption were analyzed using discrete logistic regression models. Generalized estimation equation models were used to assess the risk of incident late AMD associated with baseline AMD lesion characteristics.
The 15-year incidence and progression of AMD, and associated factors.
The 15-year incidence was 22.7% for early AMD and 6.8% for late AMD. After adjusting for competing risks, early and late AMD incidence were 15.1% and 4.1%, respectively. Age was strongly associated with early and late AMD incidence (both P < 0.0001). After age standardization to the Beaver Dam Eye Study (BDES) population, early and late AMD incidence in the BMES were 13.1% and 3.3%, respectively. Female sex and the presence of both risk alleles of CFH-rs1061170 or ARMS2-rs10490924 were independently associated with early AMD incidence, whereas current smoking and presence of ≥1 risk allele of CFH-rs1061170 or ARMS2-rs10490924 were associated with late AMD incidence. Fish consumption was inversely associated with late but not early AMD incidence. Severity of early AMD lesion characteristics was a strong predictor of progression to late AMD.
We documented the 15-year incidence of early and late AMD in an older Australian population that were comparable to BDES observations. Risk of progression to late AMD was strongly associated with severity of early AMD lesions.
评估澳大利亚老年人群中与年龄相关的黄斑变性(AMD)的 15 年发病率和进展情况。
基于人群的队列研究。
1992-1994 年期间接受检查的蓝山眼病研究(BMES)参与者(n=3654)年龄在 49 岁及以上。其中,2334 名(幸存者的 75.8%)在 5 年后(1997-1999 年)重新检查,1952 名(幸存者的 76.7%)在 10 年后(2002-2004 年)重新检查,1149 名(幸存者的 56.1%)在 15 年后(2007-2010 年)重新检查。
拍摄彩色视网膜照片,并在每次就诊时进行综合问卷调查,并进行 DNA 基因分型。视网膜照相分级由同一位分级员按照威斯康星州 AMD 分级方案进行。并排比较用于确认新出现的 AMD 病变。使用 Kaplan-Meier 估计值估计发病率。使用离散逻辑回归模型分析 AMD 发病率与年龄、性别、吸烟状况、补体因子 H(CFH)-rs1061170 和年龄相关性黄斑病变易感性 2(ARMS2)-rs10490924 多态性以及鱼类摄入之间的关联。使用广义估计方程模型评估与基线 AMD 病变特征相关的新发晚期 AMD 的风险。
15 年 AMD 的发病率和进展情况,以及相关因素。
早期 AMD 的 15 年发病率为 22.7%,晚期 AMD 的发病率为 6.8%。在考虑竞争风险后,早期和晚期 AMD 的发病率分别为 15.1%和 4.1%。年龄与早期和晚期 AMD 的发病率密切相关(均 P<0.0001)。根据 Beaver Dam Eye Study(BDES)人群进行年龄标准化后,BMES 中的早期和晚期 AMD 发病率分别为 13.1%和 3.3%。女性和 CFH-rs1061170 或 ARMS2-rs10490924 的两个风险等位基因的存在与早期 AMD 发病率独立相关,而当前吸烟和 CFH-rs1061170 或 ARMS2-rs10490924 的≥1 个风险等位基因的存在与晚期 AMD 发病率相关。鱼类摄入与晚期 AMD 但与早期 AMD 发病率无关。早期 AMD 病变特征的严重程度是进展为晚期 AMD 的强烈预测因素。
我们记录了澳大利亚老年人群中与年龄相关的黄斑变性的 15 年发病率,与 BDES 的观察结果相当。进展为晚期 AMD 的风险与早期 AMD 病变的严重程度密切相关。